Metronidazole, ranitidine and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy)

甲硝唑 克拉霉素 医学 奥美拉唑 幽门螺杆菌 内科学 胃肠病学 雷尼替丁 养生 快速尿素酶试验 抗生素 胃炎 微生物学 生物
作者
Mahmoud M. Yousfi,Hala El‐Zimaity,Rhonda A. Cole,R M Genta,David Y. Graham
出处
期刊:Alimentary Pharmacology & Therapeutics [Wiley]
卷期号:10 (1): 119-122 被引量:28
标识
DOI:10.1111/j.1365-2036.1996.tb00185.x
摘要

SUMMARY Background : Multi‐drug regimens are generally required to reliably cure Helicobarter pylori infection. Metronidazole, clarithromycin and omeprazole has proven to be an effective combination therapy with a cure rate of 90% or greater. Methods : We evaluated a 14‐day combination regimen for H. pylori infection consisting of metronidazole 500 mg b.d., clarithromycin 250 mg b.d. and ranitidine 300 mg b.d. (MRC) instead of omeprazole. Ranitidine alone was continued for an additional 4 weeks. H. pylori status was determined by rapid urease testing. histopathology using the Genta stain, and by culture at entry and 4 weeks after completing antimicrobial therapy. Results : Twenty‐seven patients with documented peptic ulcer disease and H. pylori infection were treated. Five had previously failed macrolide‐based antimicrobial therapy: none had received metronidazole. All ulcers were healed at week 6 except one patient taking naproxen; his H. pylori infection was cured. Overall, H. pylori infection was cured in 78% (95% CI = 58–91%). In patients with clarithromycin‐sensitive isolates, the cure rate was 20 of 23 (87%, 95% C.I. = 66–97%); only one of four patients (25%) with clarithromycin‐resistant isolates was cured. In contrast, four of five patients with metronidazole‐resistant isolates were cured (80%). In patients with isolates sensitive to both antibiotics, the cure rate was 16 of 18 (89% 95% C.I. = 65–99%). Mild side effects were reported by 27%, including diarrhoea and altered taste. Compliance averaged 98%. Conclusion : These results suggest that the combination of metronidazole, ranitidine and clarithromycin results in high cure rates in patients with clarithromycin‐sensitive isolates. Omeprazole may not be required for Bazzoli's triple therapy; and large multicentre comparative trials are indicated.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
2秒前
yelenag发布了新的文献求助50
5秒前
Lee发布了新的文献求助10
5秒前
橙子发布了新的文献求助10
7秒前
8秒前
科目三应助lll采纳,获得10
9秒前
曾经枫完成签到,获得积分10
9秒前
星辰大海应助lilililili采纳,获得10
10秒前
孤梦落雨发布了新的文献求助10
11秒前
完美世界应助atonnng采纳,获得10
11秒前
12秒前
ding应助adeno采纳,获得10
14秒前
hz_sz完成签到,获得积分10
14秒前
16秒前
美琦完成签到,获得积分10
17秒前
18秒前
rwang1105应助Lee采纳,获得10
19秒前
20秒前
20秒前
嘟嘟发布了新的文献求助10
24秒前
25秒前
可爱的函函应助JM采纳,获得10
25秒前
pe发布了新的文献求助10
28秒前
32秒前
起风了完成签到 ,获得积分10
32秒前
Muse应助张Morningstar采纳,获得10
32秒前
兴奋的故事完成签到,获得积分10
35秒前
35秒前
35秒前
35秒前
科研通AI2S应助科研通管家采纳,获得10
37秒前
qqa发布了新的文献求助10
37秒前
烟花应助科研通管家采纳,获得10
37秒前
科研通AI2S应助科研通管家采纳,获得10
37秒前
所所应助科研通管家采纳,获得10
37秒前
丘比特应助科研通管家采纳,获得10
37秒前
打打应助科研通管家采纳,获得10
37秒前
科研通AI2S应助科研通管家采纳,获得10
38秒前
38秒前
高分求助中
Solution Manual for Strategic Compensation A Human Resource Management Approach 1200
Natural History of Mantodea 螳螂的自然史 1000
Glucuronolactone Market Outlook Report: Industry Size, Competition, Trends and Growth Opportunities by Region, YoY Forecasts from 2024 to 2031 800
A Photographic Guide to Mantis of China 常见螳螂野外识别手册 800
Zeitschrift für Orient-Archäologie 500
Smith-Purcell Radiation 500
Autoregulatory progressive resistance exercise: linear versus a velocity-based flexible model 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 细胞生物学 免疫学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3343244
求助须知:如何正确求助?哪些是违规求助? 2970337
关于积分的说明 8643416
捐赠科研通 2650267
什么是DOI,文献DOI怎么找? 1451220
科研通“疑难数据库(出版商)”最低求助积分说明 672116
邀请新用户注册赠送积分活动 661447